Etco2 Levels on the End-tidal Concentration of Sevoflurane
- Conditions
- End-tidal Carbon DioxideMinimum Alveolar ConcentrationEnd-tidal Sevoflurane
- Interventions
- Procedure: low etco2Procedure: high etco2Procedure: normal etco2
- Registration Number
- NCT05778968
- Lead Sponsor
- Tanta University
- Brief Summary
he assessment of adequate levels of anaesthesia traditionally relies not only on a patient's movement but also on the hemodynamic response (or both) to a surgical stimulus
- Detailed Description
Currently a derivative of MAC namely, end tidal partial pressure (FET) displayed on the work station as concentration , maybe an alternative useful measure of the anaesthetic effect of an inhaled anaesthetic agent
. Many pharmacological factors have been associated with alterations in MAC and Mac derivatives such as nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and anesthetics.
However, few studies have focused on physiological factors, such as hypercarbia or hypocarbia. A correlation has been found between Paco2 and Etco2 in ventilated patients with healthy lungs. Some authors have suggested that Etco2 could be considered appropriate for estimating Paco2 even in critical patients. Knowledge of the effects of Paco2 on end tidal concentration of sevoflurane among patients undergoing laparoscopic cholecystectomy may help anaesthesiologists titrate sevoflurane carefully and precisely during different mechanical ventilation settings to avoid dose-dependent hypotension, impaired cardiac contractility, and hypothermia caused by excessive anaesthetic depth of sevoflurane.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 90
- American Society of anaesthesiologist ASA physical status I, II
- admitted for laparoscopic cholecystectomy
-
Refusal of patients.
- Patients with renal or liver dysfunction.
- Patients with chronic pain other than cholelithiasis.
- Cardiac disorders as uncontrolled hypertension, arrhythmia, Ischaemic heart disease, valvular heart disease and pulmonary hypertension.
- Patient with haematological disorder as Sickle cell disease.
- Chest patient as asthma, COPD.
- Combined surgery .
- History of allergy to any of the study drugs.
- Patients with communication problems, cognitive dysfunction, or psychological disorders.
- Patients who received analgesics or sedatives 24 h before a scheduled surgery.
- Alcohol or drug abuse.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description low ETCO2 low etco2 - high ETCO2 high etco2 - normal ETCO2 normal etco2 -
- Primary Outcome Measures
Name Time Method end tidal concentration of sevoflurane Total time of operation end tidal concentration of sevoflurane is measured by multiple gas analyser during operation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
tarek Abdelhay Mostafa
🇪🇬Tanta, El Gharbyia, Egypt